Showing results (221-230 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|June 12, 2020
Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in SpainJosep Maria Ribera Santasusana, Alejandra de Andrés Saldaña, Nuria García-Muñoz, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 29, 2021
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in SpainMaria Mareque, Pau Montesinos, Patricia Font, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 18, 2025
Awareness and Sociodemographic Factors as Predictors of Knowledge About Health Economics and Pharmacoeconomics Among Registered Nurses: A Cross-Sectional StudyHomoud Ibrahim Alanazi, Regie Buenafe Tumala, Mousa Yahya Asiri, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 23, 2025
Economic Evaluation of Extended-Release Amphetamine (Dyanavel XR) Among Individuals with Attention-Deficit/Hyperactivity Disorder From a United States Societal PerspectiveIshveen Chopra, Jennifer Horng, Melanie S Krause, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 17, 2025
Real World Evaluation of Next-Day Molecular Respiratory Infectious Disease Testing on Healthcare Resource Utilization and CostsAndrea J French, Maren S Fragala, Azia S Evans, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 11, 2025
Cost-Benefit Analysis of Genetic Testing as a Prenatal Diagnostic Tool for Thalassemia: A Single-Center Study From Central ThailandKwandao Malasai, Jiraphun Jittikoon, Wanvisa Udomsinprasert, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 25, 2025
Using QIP-MS to Guide the Timing of MRD Testing in Patients With Multiple Myeloma: A Budget Impact Analysis From the French Payer PerspectiveChristian Siegfried, Miyuru Amarapala, Xavier Leleu, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 24, 2025
Budget Impact and Cost-Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in ThailandPoukwan Arunmanakul, Tuangrat Phodha, Sakkarin Pinta-Ay, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 11, 2025
Real World Evidence on Hormone Receptor Positive and Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer in Italy: Insights From 2017 to 2021 DataValentina Perrone, Melania Leogrande, Maria Cappuccilli, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 12, 2024
Health Technology Assessment for Fast-Track Elective Knee and Hip Arthroplasty in a High-Volume Orthopaedic Hospital in ItalyUmberto Restelli, Jacopo Vitale, Edoardo Croce, et al.
Pageof 102